About: Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by E H Tran et al published May 2000 in European Journal of Immunology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) article scientifique publié en 2000 (fr) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de) article by E H Tran et al published May 2000 in European Journal of Immunology (en)
publication date	wds:Q57042424-F30B96B3-0404-4E42-8948-1D68D0BC5112
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57042424-46C4A958-C4E6-493F-8AAA-22DF705FEB75
language of work or name	English
author name string	wds:Q57042424-3E1B3D14-6B41-4D8C-A6A3-772912816752 wds:Q57042424-4335050D-6A39-4DB1-9064-BB704DB531C2 wds:Q57042424-BFF547AA-5594-4974-B8CC-97EF9FAA3532
author name string	T Owens W A Kuziel E H Tran
rdfs:label	Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (en) Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (nl)
skos:prefLabel	Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (en) Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (nl)
name	Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (en) Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (nl)
title	wds:Q57042424-3D8CFC49-A83E-4938-9D44-2137C3E7AB4B
title	Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor (en)
page(s)	wds:Q57042424-C39D9272-DD2A-4A01-85D1-2E7495F5AEA4
page(s)	1410-5
instance of	wds:Q57042424-515ED381-227F-4F46-A773-7051AB4652F8
instance of	scholarly article
main subject	wds:Q57042424-5B5C5E37-C038-467C-AE8E-9E033BE6940C wds:Q57042424-6718D413-14F6-4060-AE2A-2876FE2279BE wds:Q57042424-F9DC8207-481B-4B14-B1CC-DEC3D1AFE5D0
main subject	experimental autoimmune encephalomyelitis inflammation macrophage
PubMed ID	wds:Q57042424-403806DC-204F-4F17-8009-DA2C7ECFF958
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10820388
PubMed ID	10820388
published in	wds:Q57042424-9CE69D4A-564A-4A2C-8A0E-75AEB3D23F72
published in	European Journal of Immunology
issue	wds:Q57042424-C35C2C59-108A-421F-B6D7-B1ED5AB5B57E
volume	wds:Q57042424-C2209620-141F-4D85-AC6D-BAF8BDDCCB3F
issue	5
volume	30
DOI	wds:Q57042424-FF1EE17C-81C2-4B74-BF16-1B148D504729
DOI	http://dx.doi.org/10.1002/(SICI)1521-4141(200005)30:5%3C1410::AID-IMMU1410%3E3.0.CO;2-L
DOI	10.1002/(SICI)1521-4141(200005)30:5<1410::AID-IMMU1410>3.0.CO;2-L
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57042424
is cites work of	Genetic models for CNS inflammation CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. G protein-coupled receptors as therapeutic targets for multiple sclerosis Chemokines as novel therapeutic targets in inflammatory diseases Chemokine receptors: multifaceted therapeutic targets International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors Delta-like ligand 4 regulates central nervous system T cell accumulation during experimental autoimmune encephalomyelitis CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design Three or more routes for leukocyte migration into the central nervous system Chemokines and disease Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system Involvement of beta-chemokines in the development of inflammatory demyelination Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis The blood-brain barrier, chemokines and multiple sclerosis Targeting the "cytokine storm" for therapeutic benefit Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments Chemokine receptor antagonism as an approach to anti-inflammatory therapy: 'just right' or plain wrong? CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1 Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. Chemokines and central nervous system disorders CCR5 deficiency does not reduce hypertensive end-organ damage in mice. Chemokine receptors in inflammation: an overview An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking T cell responses in the central nervous system CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis. Protective role for CCR5 in murine lupus nephritis. Chemokines as targets for therapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software